Search

Brexit is clouding its future role in the new common patent, but Benoit Battistelli, head of the European Patent Office thinks there are ways to keep the UK in the system

An agreement between the pharma industry and health care providers in Manchester will collect real-world data on the value of drugs. The aim is to open the door to fixing drug prices based on how effective they are in everyday use

With little sign of German flexibility on tech issues ahead of Brexit negotiations, the UK could have better luck extracting concessions from France

Mark Ferguson makes no bones about the opportunities, saying “With Brexit, there is more upside than downside for Irish science”

ETH material scientists have developed a new method of manufacturing ceramics that does not require the starting materials to be fired. Instead, they are compacted under high pressure at room temperature in a significantly more energy-efficient process.

The third edition of the Regional Competitiveness Index compares 263 EU regions, providing useful insights for boosting economic and innovation performance.

The WHO’s first-ever list of antibiotic-resistant “priority pathogens” names 12 families of bacteria that pose the greatest threat to humans. The list is intended to ensure R&D responds to public health needs

Aix-Marseille University opens call for applications to its DOC2AMU doctoral programme

EU-funded researchers in poorer member states will get higher wages after politicians argued the current remuneration structure fuels an east-to-west brain drain. But it is not clear how much the increase will cost - or how it will be funded

Systemic failings persist in the science systems of several member states, the EU executive finds in its latest country assessments.

A total of 36 research projects will explore challenges posed by big data in informatics infrastructure and ethics

Relaxed rules on massing and analysing data for commercial gain viewed as an opportunity for the UK after it leaves the bloc

Companies working to commercialise the use of Crispr–Cas9 in human therapies are choosing the US over Europe to raise money

Greg Arrowsmith of the Association of European Renewable Energy Research Centres, responds to clean tech entrepreneur Michael Liebreich’s contention that Horizon 2020 is having little impact. You need to look in the right places, he says